LIPO Drug Patent Profile
✉ Email this page to a colleague
When do Lipo patents expire, and what generic alternatives are available?
Lipo is a drug marketed by Roche, 3M, Cipher Pharms Inc, Abbott, and Hospira. and is included in ten NDAs.
The generic ingredient in LIPO is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIPO?
- What are the global sales for LIPO?
- What is Average Wholesale Price for LIPO?
Summary for LIPO
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for LIPO |
| DailyMed Link: | LIPO at DailyMed |
US Patents and Regulatory Information for LIPO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | LIPO GANTRISIN | sulfisoxazole acetyl | EMULSION;ORAL | 009182-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | LIPOSYN II 10% | safflower oil; soybean oil | INJECTABLE;INJECTION | 018997-001 | Aug 27, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | LIPOSYN III 10% | soybean oil | INJECTABLE;INJECTION | 018969-001 | Sep 24, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
